Table 1 |
||||
|
Patient's diagnosis, sex, middle age and presence of nodular metastases |
||||
| Diagnosis |
Patients sex |
|||
|
|
||||
| M |
F |
Patients Age (mean, SD) |
Lymph Node metastases |
|
|
|
||||
| PTC (all) |
14 |
51 |
||
|
|
||||
| PTC (classical variant) |
10 |
43 |
46 ± 17.22 |
19 |
|
|
||||
| PTC (follicular variant) |
4 |
6 |
32 ± 18.52 |
4 |
|
|
||||
| PTC (oxyphilic variant) |
0 |
1 |
42 |
0 |
|
|
||||
| PTC (cribrifirm-morular variant) |
0 |
1 |
22 |
0 |
|
|
||||
| Nodular goiter with benign nodular hyperplasia |
1 |
10 |
44 ± 13.71 |
- |
|
|
||||
| Lymphocytic thyroiditis |
0 |
9 |
50 ± 13.07 |
- |
|
|
||||
| Follicular adenoma |
1 |
7 |
46 ± 12.84 |
- |
|
|
||||
| FTC |
0 |
4 |
48 ± 14.49 |
0 |
Nikiel et al. Thyroid Research 2009 2:5 doi:10.1186/1756-6614-2-5 |
||||
